About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 454 trials

TerminatedSafety and Efficacy of Kanglaite Gelcaps in Prostate CancerThis research is being done to evaluate the safety and efficacy of the investigational Kanglaite gelcap (KLTc) on PSA in men with prostate cancer when given for twelve months.NCT01483586·Chicago, Illinois and 4 others Active not recruitingA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesResearchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.NCT05794906·Phoenix, Arizona and 225 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

WithdrawnPhase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)This research is being done to test the safety and anti-cancer activity of the combination of an investigational drug called orteronel, with a drug called itraconazole in the…NCT02054793·Washington D.C., District of Columbia and 2 others

CompletedEffect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical ProstatectomyThe ability of sildenafil to aid in the return of erections after nerve-sparing radical prostatectomy has been established.NCT00511498·Baltimore, Maryland

CompletedBi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerThis pilot study is designed to determine the feasibility and safety of administering docetaxel at various dosing levels on a bi-weekly schedule in older men with hormone…NCT00215709·Baltimore, Maryland

TerminatedAn Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerThis Phase 2 Open-label Study examines the efficacy, safety, tolerability, and pharmacokinetics (PK) of tomivosertib (eFT508) in Patients with advanced CRPC.NCT03690141·New Haven, Connecticut and 9 others

CompletedImproving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyThe purpose of this phase II trial is to determine the efficacy and safety of testosterone replacement therapy (TRT) in improving the symptoms of androgen deficiency and…NCT03716739·Baltimore, Maryland and 2 others

Active not recruitingSafety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate CancerThe purpose of this first-in-man study is to evaluate safety and tolerability of ODM-208 in patients with metastatic castration-resistant prostate cancer.NCT03436485·Baltimore, Maryland and 19 others

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

CompletedA Survivorship Care Plan and Embedded Navigation ToolThis is a parallel group, multisite prospective clinical study.NCT03424837·Tampa, Florida and 5 others

CompletedOptimization of Prostate Biopsy - Micro-Ultrasound Versus MRIOPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate…NCT05220501·Los Angeles, California and 21 others

CompletedSpaceOAR System Pivotal StudyEvaluate the safety of the SpaceOAR System when the hydrogel is injected between the rectum and prostate in men undergoing radiation therapy (IG-IMRT)NCT01538628·Phoenix, Arizona and 19 others

CompletedPhase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerThe VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival…NCT02111577·Mobile, Alabama and 176 others

RecruitingTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine CellsThis phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places…NCT05691465·Duarte, California and 12 others

CompletedI-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).This clinical trial was done to show whether a radioactive drug (I-131-1095) that binds to prostate-specific membrane antigen (PSMA) is useful in treating metastatic prostate…NCT03939689·Duarte, California and 26 others

WithdrawnA Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomyThis study investigates the pathologic effects of the combination of enzalutamide, abiraterone acetate, dutasteride, and degarelix when given for 12 weeks prior to prostatectomy…NCT02159690·Baltimore, Maryland

CompletedA Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.NCT00036543·Homewood, Alabama and 231 others

TerminatedNeoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerThis is a single-center, single arm, open-label phase II study evaluating the safety, anti-tumor effect, and immunogenicity of neoadjuvant Dupixent given prior to radical…NCT03886493·Baltimore, Maryland

CompletedRobot-Assisted MRI-Guided Prostate BiopsyProstate biopsies are commonly performed freehanded under transrectal ultrasound guidance (TRUS).NCT02080052·Baltimore, Maryland

PreviousPage 18 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma